Clinical trial to assess whether addition of Lignocaine to intramuscular injection of Magnesium Sulpate reduces pain in women with toxemia of pregnancy.

Assessment of pain associated with intramuscular injection of Magnesium Sulphate with or without Lignocaine in women with severe preeclampsia and conscious eclamptic womenâ?? A Randomized Control Trial.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/03/004503

Enrollment

Registered

2014-03-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Severe preeclampsia and conscious eclamptics.

Interventions

Intervention1: Magnesium Sulphate with Lignocaine.: IM injection of 2.5gm/5gm Magnesium Sulphate with 1ml of 2%Lignocaine every 4th hourly untill the delivery or upto 24hrs from the last fit whicheve

Eligibility

Inclusion criteria

Inclusion criteria: All cases of severe pre eclampsia and eclampsia-antepartum, intrapartum,postpartum(convulsion occuring within 48 hrs of delivery).

Exclusion criteria

Exclusion criteria: Known case of Epilepsy. Not willing to participate.

Design outcomes

Primary

Measure	Time frame
Pain assessment with visual analog scale.Timepoint: At 5mins of injection,at the end of 4hours,4hours last dose.	—

Secondary

Measure	Time frame
Pain assessment with visual analog scale.Timepoint: At 5mins of injection,at the end of 4hours,4hours last dose.	—

Countries

India

Contacts

Public ContactDr Swathi A

KLE university

mbbellad@hotmail.com9448124893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026